{"id": "patient_01_q0", "query": "Which of the following is NOT part of the current treatment regimen for Mrs. Sample's DLBCL?", "options_scores": {"A": 0.0003591848653741181, "B": 2.940434933407232e-05, "C": 7.190984615590423e-05, "D": 1.8272510766983032, "E": 4.593353150994517e-05}, "ranked_options": [{"letter": "B", "text": "Rituximab", "avg_nll": 2.940434933407232e-05}, {"letter": "E", "text": "Doxorubicin", "avg_nll": 4.593353150994517e-05}, {"letter": "C", "text": "Cyclophosphamide", "avg_nll": 7.190984615590423e-05}, {"letter": "A", "text": "Polatuzumab vedotin", "avg_nll": 0.0003591848653741181}, {"letter": "D", "text": "Vincristine", "avg_nll": 1.8272510766983032}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q1", "query": "In the context of Mrs. Sample's other diagnoses, which of the following is NOT accurate based on the provided information?", "options_scores": {"A": 3.0148375034332275, "B": 0.9612495303153992, "C": 1.5548841953277588, "D": 1.6291882991790771, "E": 2.2205302715301514}, "ranked_options": [{"letter": "B", "text": "She was diagnosed with primary progressive type of multiple sclerosis.", "avg_nll": 0.9612495303153992}, {"letter": "C", "text": "She has a mood disorder.", "avg_nll": 1.5548841953277588}, {"letter": "D", "text": "She has 3-vessel CHD.", "avg_nll": 1.6291882991790771}, {"letter": "E", "text": "She has pre-existing ALS.", "avg_nll": 2.2205302715301514}, {"letter": "A", "text": "She has 2-vessel disease", "avg_nll": 3.0148375034332275}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q2", "query": "Which chronic, neuroinflammatory disease does Mrs. Sample suffer from? ", "options_scores": {"A": 4.019570827484131, "B": 4.726688861846924, "C": Infinity, "D": 4.647664546966553, "E": 1.6341125965118408}, "ranked_options": [{"letter": "E", "text": "Autoimmune encephalitis", "avg_nll": 1.6341125965118408}, {"letter": "A", "text": "Multiple sclerosis", "avg_nll": 4.019570827484131}, {"letter": "D", "text": "Brain abscess", "avg_nll": 4.647664546966553}, {"letter": "B", "text": "Dementia", "avg_nll": 4.726688861846924}, {"letter": "C", "text": "Parkinson", "avg_nll": null}], "correct_answer_letter": "A", "error": null, "method": "local"}
{"id": "patient_01_q3", "query": "Mrs. Sample takes Fingolimod. What is the dosis and when does the patient take it?", "options_scores": {"A": 0.9815127849578857, "B": 1.332362413406372, "C": 1.2343409061431885, "D": 2.766629457473755, "E": 1.9489227533340454}, "ranked_options": [{"letter": "A", "text": "0.5 mg, 1 capsule in the morning", "avg_nll": 0.9815127849578857}, {"letter": "C", "text": "50 mg, 1 capsule in the morning", "avg_nll": 1.2343409061431885}, {"letter": "B", "text": "0.5 mg, 1 capsule at bedtime", "avg_nll": 1.332362413406372}, {"letter": "E", "text": "70 mg, 1 capsule in the morning", "avg_nll": 1.9489227533340454}, {"letter": "D", "text": "35 mg, 1 capsule at bedtime", "avg_nll": 2.766629457473755}], "correct_answer_letter": "B", "error": null, "method": "local"}
{"id": "patient_01_q4", "query": "Which therapy regime does the oncology board recommend for Mrs. Sample?", "options_scores": {"A": 4.546588897705078, "B": 5.181381702423096, "C": 5.073604106903076, "D": 1.5944302082061768, "E": 5.010281085968018}, "ranked_options": [{"letter": "D", "text": "6 cycles of R-Pola-CHP", "avg_nll": 1.5944302082061768}, {"letter": "A", "text": "5 cycles of T-Pola-RHP", "avg_nll": 4.546588897705078}, {"letter": "E", "text": "8 cycles of M-Pola-CHZ", "avg_nll": 5.010281085968018}, {"letter": "C", "text": "6 cycles of L-Pola-CRP", "avg_nll": 5.073604106903076}, {"letter": "B", "text": "7 cycles of R-Luna-CHT", "avg_nll": 5.181381702423096}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q5", "query": "Mrs. Sample has bone metastasis, of which one was surgically addressed. Where was this metastasis located? ", "options_scores": {"A": 2.0935051441192627, "B": 2.1060051918029785, "C": 1.9664874076843262, "D": 2.2060706615448, "E": 2.0862789154052734}, "ranked_options": [{"letter": "C", "text": "Thoracic vertebra 10", "avg_nll": 1.9664874076843262}, {"letter": "E", "text": "Thoracic vertebra 12", "avg_nll": 2.0862789154052734}, {"letter": "A", "text": "Thoracic vertebra 8", "avg_nll": 2.0935051441192627}, {"letter": "B", "text": "Thoracic vertebra 9", "avg_nll": 2.1060051918029785}, {"letter": "D", "text": "Thoracic vertebra 11", "avg_nll": 2.2060706615448}], "correct_answer_letter": "C", "error": null, "method": "local"}
{"id": "patient_01_q6", "query": "On 01/09/2017, Mrs. Sample received a CT scan of her whole body. What kind of contrast agent was used?", "options_scores": {"A": 2.262561321258545, "B": 4.4259843826293945, "C": 3.7053890228271484, "D": 4.447165012359619, "E": 4.612503528594971}, "ranked_options": [{"letter": "A", "text": "Omnipaque 320", "avg_nll": 2.262561321258545}, {"letter": "C", "text": "Optiray 320", "avg_nll": 3.7053890228271484}, {"letter": "B", "text": "Imeron 400", "avg_nll": 4.4259843826293945}, {"letter": "D", "text": "Gadovist", "avg_nll": 4.447165012359619}, {"letter": "E", "text": "Xenetix 350", "avg_nll": 4.612503528594971}], "correct_answer_letter": "A", "error": null, "method": "local"}
{"id": "patient_01_q7", "query": "Mrs. Sample received multiple radiologic examinations. In which order did she receive them?", "options_scores": {"A": 2.3275465965270996, "B": 1.8421123027801514, "C": 3.198685884475708, "D": 2.4616875648498535, "E": 2.1970417499542236}, "ranked_options": [{"letter": "B", "text": "MR Brain > MR thoracic/lumbar spine > CT chest/abdomen/pelvis > CT Thoracic Spine > CT Thoracic Spine > CT chest/abdomen/pelvis > Abdominal ultrasound > MR Spine > Whole-body PET/CT > Liver MRI", "avg_nll": 1.8421123027801514}, {"letter": "E", "text": "CT Thoracic Spine > CT Whole Body > MR cervical spine > MR Head", "avg_nll": 2.1970417499542236}, {"letter": "A", "text": "MR spine > MR Head > CT Thoracic Spine > CT Whole Body", "avg_nll": 2.3275465965270996}, {"letter": "D", "text": "MR Brain > CT Thoracic Spine > MR cervical spine > CT Whole Body", "avg_nll": 2.4616875648498535}, {"letter": "C", "text": "MR cervical spine > MR Head > CT Whole Body > CT Thoracic Spine", "avg_nll": 3.198685884475708}], "correct_answer_letter": "B", "error": null, "method": "local"}
{"id": "patient_01_q8", "query": "Mrs. Sample’ medications changed between admission and discharge. Which of the following statements is correct?", "options_scores": {"A": 1.3118841648101807, "B": 2.442136526107788, "C": 0.9588078260421753, "D": 2.036229372024536, "E": 2.6086504459381104}, "ranked_options": [{"letter": "C", "text": "The dose of Sertraline hydrochloride was increased from 50 mg to 100 mg.", "avg_nll": 0.9588078260421753}, {"letter": "A", "text": "Aspirin was discontinued.", "avg_nll": 1.3118841648101807}, {"letter": "D", "text": "The patient started taking prednisolone and is recommended to continue taking it for the rest of her life.", "avg_nll": 2.036229372024536}, {"letter": "B", "text": "The patient started taking Pregabalin 50 mg, 1-0-0-0", "avg_nll": 2.442136526107788}, {"letter": "E", "text": "The patient started taking 2mg of Melatonin in the evening.", "avg_nll": 2.6086504459381104}], "correct_answer_letter": "E", "error": null, "method": "local"}
{"id": "patient_01_q9", "query": "Based on the medication changes from admission to discharge, which of the following best describes the Mrs Sample's evolving clinical situation?", "options_scores": {"A": 3.3118433952331543, "B": 3.075780153274536, "C": 3.432041645050049, "D": 2.8322644233703613, "E": 3.675746202468872}, "ranked_options": [{"letter": "D", "text": "The patient's mood disorder was deemed stabilized, leading to the discontinuation of Sertraline at discharge.", "avg_nll": 2.8322644233703613}, {"letter": "B", "text": "The patient's pain management was escalated, as indicated by an increased frequency of Hydromorphone intake.", "avg_nll": 3.075780153274536}, {"letter": "A", "text": "The patient's cardiovascular risk was decreased, leading to a reduced number of cardiovascular medications at discharge.", "avg_nll": 3.3118433952331543}, {"letter": "C", "text": "The patient developed a new gastrointestinal issue, hence the introduction of Pantoprazole at discharge.", "avg_nll": 3.432041645050049}, {"letter": "E", "text": "The patient's immobility concerns were resolved, leading to the discontinuation of Enoxaparin sodium (Clexane®) at discharge.", "avg_nll": 3.675746202468872}], "correct_answer_letter": "B", "error": null, "method": "local"}
